Sodium-glucose cotransporter-2 (SGLT2) inhibitors, used in patients with diabetes, can cause diabetic ketoacidosis. This is rare but can be serious and life threatening. The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) warn about possible “atypical” presentation of diabetic ketoacidosis with SGLT2 inhibitors: instead of having hyperglycaemia, patients may have normal or only mildly elevated blood glucose levels (<13.9 mmol/L, <250 mg/dL). This may delay diagnosis. In 2020, theFDAandEMAupdated guidance to interrupt SGLT2 inhibitors and monitor ketosis in patients scheduled for surgery or hospitalised.

Diabetic ketoacidosis with SGLT2 inhibitors

Musso, Giovanni
First
;
Saba, Francesca;Cassader, Maurizio;Gambino, Roberto
Last
2020-01-01

Abstract

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, used in patients with diabetes, can cause diabetic ketoacidosis. This is rare but can be serious and life threatening. The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) warn about possible “atypical” presentation of diabetic ketoacidosis with SGLT2 inhibitors: instead of having hyperglycaemia, patients may have normal or only mildly elevated blood glucose levels (<13.9 mmol/L, <250 mg/dL). This may delay diagnosis. In 2020, theFDAandEMAupdated guidance to interrupt SGLT2 inhibitors and monitor ketosis in patients scheduled for surgery or hospitalised.
2020
BMJ
371
1
4
https://www.bmj.com/content/371/bmj.m4147
Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto
File in questo prodotto:
File Dimensione Formato  
BMJ.ADR-SGLT2-DKA_2020.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 711.14 kB
Formato Adobe PDF
711.14 kB Adobe PDF Visualizza/Apri
Diabetic ketoacidosis with SGLT2 inhibitors.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.42 MB
Formato Adobe PDF
1.42 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1765340
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 48
social impact